Sree Rayalaseema Hi-Strength Hypo growth over the years

·ChemicalsChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Compounded a year1 yr3 yr
Revenue+4.6%−26.1%
EBITDA−3.9%−20.7%
Net Income+3.1%−16.4%
EPS (adj.)+3.1%−16.4%
Total Assets+4.2%+6.5%
Total Equity+5.4%+9.4%
Free Cash Flow−47.7%−37.0%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

SRHHYPOLTD₹499.15

Sree Rayalaseema Hi-Strength Hypo Limited

· Chemicals
₹ CrorePeersGEMAROMADMCCSUDARCOLORJAYAGROGNKRONOXAMNPLSTCHEMFABPRIMOMcap ₹857 Cr
Annuals · FY-end closes
Compounded Growth
Annuals · CAGR %
1Y
CAGR
3Y
CAGR
Revenue+4.6-26.1
EBITDA-3.9-20.7
Net Income+3.1-16.4
EPS (adj.)+3.1-16.4
Total Assets+4.2+6.5
Total Equity+5.4+9.4
Free Cash Flow-47.7-37.0
CAGR from filed annuals — needs positive start & end values.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.